$4.71
0.24.43%
Pre-Market: 8:41 AM EDT
Comments
Loading...
Traws Pharma (TRAW) Forecast
NewsEarningsTraws Pharma (TRAW) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestTraws Pharma (NASDAQ:TRAW) Stock Quotes, Forecast and News Summary
Traws Pharma Stock (NASDAQ: TRAW) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Traws Pharma (TRAW) stock?
You can purchase shares of Traws Pharma (NASDAQ:TRAW) through any online brokerage.
Who are Traws Pharma (TRAW) competitors?
Other companies in Traws Pharma’s space includes: Cingulate (NASDAQ:CING), Cumberland (NASDAQ:CPIX), Gelteq (NASDAQ:GELS), Cocrystal Pharma (NASDAQ:COCP) and Kiora Pharmaceuticals (NASDAQ:KPRX).
What is the forecast, or price target, for Traws Pharma (TRAW) stock?
There is no analysis for Traws Pharma to provide a consensus price target.
What is the current price for Traws Pharma (TRAW)?
The stock price for Traws Pharma (NASDAQ: TRAW) is $4.71 last updated November 21, 2024 at 8:41 AM EST.
Does Traws Pharma (TRAW) pay a dividend?
There are no upcoming dividends for Traws Pharma.
When is Traws Pharma (NASDAQ:TRAW) reporting earnings?
Traws Pharma’s Q3 earnings are confirmed for Thursday, November 14, 2024.
Is Traws Pharma (TRAW) going to split?
There is no upcoming split for Traws Pharma.
What sector and industry does Traws Pharma (TRAW) operate in?
Traws Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.